BBIO
$76.80-0.72%
as of close, Nov 17, 2026
☾ AH $76.80 -0.72%
BridgeBio Pharma Inc.Stock · HealthcareNasdaq Composite · 0.03% of ONEQUS Stock Market · 0.02% of VTIRussell 1000 · 0.02% of IWBRussell 3000 · 0.02% of IWV
Head-to-head:Compare with ASND or any ticker →
BridgeBio Pharma Inc. total returns by year (including dividends)
As of market close, Nov 17, 2026
Every year since 2019#
Data provided bySource: Twelve DataCalendar-year returns with each year's path and its dividend contribution (dividend return = total minus price return). Every year has a direct link you can bookmark or share.
| Year | Start | End | Path | Dividend | Total return |
|---|---|---|---|---|---|
| 2026YTD | $76.49 | $76.80 | 0.0% | +0.4% | |
| 2025 | $27.44 | $76.49 | 0.0% | +178.8% | |
| 2024 | $40.37 | $27.44 | 0.0% | -32.0% | |
| 2023 | $7.62 | $40.37 | 0.0% | +429.8% | |
| 2022 | $16.68 | $7.62 | 0.0% | -54.3% | |
| 2021 | $71.11 | $16.68 | 0.0% | -76.5% | |
| 2020 | $35.05 | $71.11 | 0.0% | +102.9% | |
| 2019since Jun 27 | $27.55 | $35.05 | 0.0% | +27.2% |
- Annualized
- +15.2%
- 2020–2026
- Average year
- +91.4%
- 6 full years
- Best year
- +429.8%
- 2023
- Worst year
- -76.5%
- 2021
- Positive years
- 3/6
- 50% up
Annualized (CAGR)
+15.2%
2020–2026
Average year
+91.4%
6 full years
Best year
+429.8%
2023
Worst year
-76.5%
2021
Positive years
3/6
50% up
Total return by period#
Annual
−600%−400%−200%0%200%400%600%
2019, since Jun 27+27%'19
2020+103%'20
2021-77%'21
2022-54%'22
2023+430%'23
2024-32%'24
2025+179%'25
2026+0.41%'26
Methodology#
Total returns, dividends reinvested, measured on BBIO. Annualized return is the compound annual growth rate; the current year is year-to-date. Past performance does not predict future returns.
FAQ#
- What is BridgeBio Pharma Inc.'s average annual return?
- Since 2020, BridgeBio Pharma Inc. (BBIO) has returned about 15.2% a year (the compound annual growth rate) and an average calendar-year return of 91.4%.
- What were BridgeBio Pharma Inc.'s best and worst years?
- Over 2020–2026, the best year was 2023 (+429.8%) and the worst was 2021 (-76.5%).
- How often is BridgeBio Pharma Inc. up in a year?
- 3 of the 6 full years since 2020 were positive — about 50% of the time.
More on BridgeBio Pharma Inc.
Annual returns for: S&P 500 · S&P 500 Equal Weight · US Stock Market · Nasdaq-100
Head-to-head:Compare with ASND or any ticker →
